Boston Scientific (NYSE:BSX) recently reported its Q4 results, which were in line with our estimates. The top line grew in mid-single-digits while the adjusted earnings of $0.39 per share was up in low double-digits. This can be attributed to steady growth in all segments, primarily MedSurg, which..
Boston Scientific's Q4 Earnings And What Lies Ahead For The Company In 2019
Forbes - 11 Feb 2019 22:11
Boston Scientific (NYSE:BSX) recently reported its Q4 results, which were in line with our estimates. The top line grew in mid-single-digits while the adjusted earnings of $0.39 per share was up in low double-digits. This can be attributed to steady growth in all segments, primarily MedSurg, which..
Share this Article
Recommended